Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tdf Taf'

Tdf Taf published presentations and documents on DocSlides.

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

  • kittie-lecroy
  • 32 Slides

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

  • giovanna-bartolotta
  • 13 Slides

“On Demand” Oral PrEP: Lessons Learned from M...

Gilead Sciences, Inc., Foster City, CA, USA

Gilead Sciences, Inc., Foster City, CA, USA

  • phoebe-click
  • 19 Slides

Gilead Sciences, Inc., Foster City, CA, USA FTC/T...

Common Pharmacomistakes in Advanced Illness

Common Pharmacomistakes in Advanced Illness

  • tawny-fly
  • 42 Slides

Common Pharmacomistakes in Advanced Illness Opioi...

CROI Update: Best of Boston

CROI Update: Best of Boston

  • triclin
  • 54 Slides

p. resented by. NCATEC. March . 18, . 2014. David ...

HIV Medicine From Guidelines to Practice

HIV Medicine From Guidelines to Practice

  • jubilantbikers
  • 63 Slides

Kiat. . Ruxrungtham. Professor of Medicine, . Chu...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Comparison of RTV vs Cobi

Comparison of RTV vs Cobi

  • studmonkeybikers
  • 11 Slides

GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...

937401234123534671341849346744x 19 333133Webinar Requirements A c

937401234123534671341849346744x 19 333133Webinar Requirements A c

  • erica
  • 72 Slides

HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...

Target Date Funds and P

Target Date Funds and P

  • unita
  • 12 Slides

lan . S. ponsor Responsibilities. Marcia S. Wagner...

Eric S. Daar , MD Michael S.

Eric S. Daar , MD Michael S.

  • ButterflyHeart
  • 41 Slides

Saag. , MD. Antiretroviral Therapy:. A Case-Based ...

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

  • alyssa
  • 7 Slides

302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

Jeanne Marrazzo, MD, MPH

Jeanne Marrazzo, MD, MPH

  • rose
  • 9 Slides

Professor of Medicine. University of Washington. S...

Cabotegravir, Long-acting Injectable

Cabotegravir, Long-acting Injectable

  • jacey
  • 34 Slides

Last Updated: October 6, 2023. Prepared by:. David...

HIV 2020: Time for change

HIV 2020: Time for change

  • garcia
  • 38 Slides

Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...

Retirement Plan Consulting

Retirement Plan Consulting

  • oconnor
  • 30 Slides

Overview of Services. Table of Contents. About RPA...

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

  • felicity
  • 8 Slides

ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...

NRTI-sparing SPARTAN PROGRESS

NRTI-sparing SPARTAN PROGRESS

  • shepard237
  • 5 Slides

RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

  • ricardo
  • 9 Slides

ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

  • matthew167
  • 11 Slides

NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...

Innovative Strategies for the Management

Innovative Strategies for the Management

  • karlyn-bohler
  • 37 Slides

of HIV Infection. Dual therapies without NRTIs. J...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Update on risk factors, detection, and management of neuroc

Update on risk factors, detection, and management of neuroc

  • natalia-silvester
  • 61 Slides

Scott Letendre, M.D.. Professor of . Medicine and...

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

  • calandra-battersby
  • 81 Slides

Adults:. . Implications . for Clinical Practice....

COMING SOON:

COMING SOON:

  • luanne-stotts
  • 31 Slides

GENERIC ARVs. Tim Horn. Treatment Action Group. t...

TDF Microsoft Lync - Novembre 2010

TDF Microsoft Lync - Novembre 2010

  • faustina-dinatale
  • 9 Slides

Solutions & Architectures UC . Polycom. - Mi...

CROI 2015: HIV Prevention Updates

CROI 2015: HIV Prevention Updates

  • pamella-moone
  • 24 Slides

Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...

Switch to ATV/

Switch to ATV/

  • cheryl-pisano
  • 16 Slides

r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Highlights of AIDS

Highlights of AIDS

  • calandra-battersby
  • 44 Slides

2016: Advances in . HIV Prevention, Care and Trea...

ID Week 2016: HIV Update

ID Week 2016: HIV Update

  • min-jolicoeur
  • 25 Slides

Robert Harrington, M.D.. ID Week 2016: HIV Update...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

  • pamella-moone
  • 7 Slides

QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

  • lois-ondreau
  • 55 Slides

GROWN CEREALS AND THEIR RELATIONSHIPS. Dr. . Mirj...

PrEP Training for

PrEP Training for

  • tatyana-admore
  • 124 Slides

Providers in Clinical Settings. 2. Welcome!. Plea...

Treatment-Experienced Patients in Resource-Limited Settings

Treatment-Experienced Patients in Resource-Limited Settings

  • pasty-toler
  • 12 Slides

Susan M. Graham . Assistant Professor, Medicine a...

Switch to PI/r + 3TC

Switch to PI/r + 3TC

  • lois-ondreau
  • 6 Slides

vs. PI/r . monotherapy. Study PIVOT. Study MOBID...

CROI 2015: What’s New in Hepatitis?

CROI 2015: What’s New in Hepatitis?

  • myesha-ticknor
  • 19 Slides

Nina Kim, MD . Associate Professor of Medicine. D...

Les satisfactions : traitements efficaces, robustes, avec u

Les satisfactions : traitements efficaces, robustes, avec u

  • phoebe-click
  • 23 Slides

Dr Denis Lacoste. Bordeaux. Les satisfactions : ....

A Demonstration Open Label

A Demonstration Open Label

  • jane-oiler
  • 0 Slides

Study to Assess the . Acceptability. , Safety. a...

Copyright © 2024 DocSlides. All Rights Reserved